Session information

[JSNM]Oral

Annual Scientific Meeting of the Japanese Society of Nuclear Medicine Program » 一般演題

Oral 01:Chemistry 1

Thu. Nov 7, 2024 8:30 AM - 9:30 AM Room 3 (5F 511+512, Conference Center, PACIFICO Yokohama)

座長：向高弘（神戸薬科大学薬品物理化学研究室）、上原知也（千葉大学大学院薬学研究院分子画像薬品学研究室）

+Add all to schedule

[1-MO01-1] Synthesis and evaluation of radiopharmaceutical targeting FAP to improve tumor retention

Kosuke Saito、Hiroyuki Watanabe、Masahiro Ono (Graduate School of Pharmaceutical Sciences, Kyoto University, Kyoto, Japan)

[1-MO01-2] Development of novel GRPR-targeting agent containing albumin binder

Shohei Tsuchihashi、Kazuma Nakashima、Hiroyuki Watanabe、Masahiro Ono (Department of Patho-Functional Bioanalysis Graduate School of Pharmaceutical Sciences, Kyoto University, Japan)

[1-MO01-3] Development of PSMA-targeting radioligand using novel linker technology

Nobuki Kazuta、Kazuma Nakashima、Hiroyuki Watanabe、Masahiro Ono (Graduate School of Pharmaceutical Sciences, The University of Kyoto, Kyoto, Japan)

[1-MO01-4] Application of radiolabeling agents with residualizing function to anti-mesothelioma mAb

Kazuma Nakashima¹、Hiroyuki Watanabe¹、Shotaro Tsuji²、Masahiro Ono¹ (1.Graduate School of Pharmaceutical Sciences, The University of Kyoto, Kyoto, Japan、2.Department of Medical Engineering, Gunma Medical and Welfare University, Gunma, Japan)

[1-MO01-5] Improved design of tumor targeted nanoparticles for the evasion of ABC phenomenon

Reo Takahashi¹、Yumi Yamamoto¹、Yohei Saito¹、Akira Makino²、Yasushi Kiyono²、Fumihiko Yamamoto¹ (1.Faculity of Pharmaceutical Sciences, Tohoku Medical and Pharmaceutical University, Miyagi, Japan、2.Biomedical Imaging Research Center, University of Fukui, Fukui, Japan)

[1-MO01-6] Reduction of the renal radioactivity of¹¹¹In-labeled melanoma-targeting peptide

Hiroyuki Suzuki、Rikako Madokoro、Yui Terasaka、Kouki Tatsugi、Masato Matsukawa、Kento Kannaka、Tomoya Uehara (Graduate School of Pharmaceutical Sciences, Chiba University, Chiba, Japan)

▲